SandboxAQ brings its drug discovery models to Claude — no PhD in computing required
SandboxAQ has partnered with Anthropic to integrate its drug discovery AI models into Claude, allowing users to access powerful tools without needing specialized computing skills. The company aims to simplify the drug discovery process, which is traditionally expensive and time-consuming. By focusing on user accessibility, SandboxAQ hopes to transform the quantitative economy with its unique physics-grounded models.
- ▪SandboxAQ has raised over $950 million and was founded as an Alphabet spinout.
- ▪The company's large quantitative models are designed to run quantum chemistry calculations and simulate molecular dynamics.
- ▪SandboxAQ's integration with Claude allows users to interact with AI models using natural language.
Opening excerpt (first ~120 words) tap to expand
Drug discovery is one of the most expensive failures in modern industry. Finding a single viable molecule can take a decade and cost billions, and most candidates still don’t make it. A generation of AI startups has promised to fix that — most have made the problem less painful for researchers who are already technically sophisticated enough to use the tools. But SandboxAQ thinks the bottleneck isn’t the models. It’s the interface. The company has teamed up with Anthropic to integrate its scientific AI models directly into Claude — putting powerful drug discovery and materials science tools behind a conversational interface that requires no specialized computing infrastructure to use.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at TechCrunch.
Discussion
0 commentsMore from TechCrunch
